Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xeris Biopharma Holdings, Inc. | Chief Financial Officer | Common Stock | 1.42M | $3.71M | $2.61 | Jul 28, 2024 | Direct |
XERIS PHARMACEUTICALS INC | Chief Financial Officer | Common Stock | 0 | Oct 5, 2021 | Direct | ||
XERIS PHARMACEUTICALS INC | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Oct 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XERS | Xeris Biopharma Holdings, Inc. | Jan 31, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Nov 20, 2023 | 1 | $54.6K | 4 | Nov 21, 2023 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Jan 31, 2023 | 1 | $0 | 4 | Feb 1, 2023 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Jan 29, 2022 | 11 | -$454K | 4 | Aug 9, 2024 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Nov 10, 2021 | 1 | $49.9K | 4 | Nov 12, 2021 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Oct 5, 2021 | 7 | $0 | 4 | Oct 5, 2021 | Chief Financial Officer |
XERS | XERIS PHARMACEUTICALS INC | Oct 5, 2021 | 7 | $0 | 4 | Oct 5, 2021 | Chief Financial Officer |
XERS | Xeris Biopharma Holdings, Inc. | Oct 5, 2021 | 0 | $0 | 3 | Oct 5, 2021 | Chief Financial Officer |
XERS | XERIS PHARMACEUTICALS INC | Jul 28, 2021 | 1 | $0 | 4 | Jul 29, 2021 | Chief Financial Officer |
XERS | XERIS PHARMACEUTICALS INC | Jul 28, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Senior Vice President, General Counsel and Corporate Secretary Exhibit 24.1: Power of Attorney attached |